Development and validation of a novel bioanalytical method for the simultaneous determination of glecaprevir and pibrentasvir in human plasma using reversed-phase high-performance liquid chromatography-Reference-Cited by-同舟云学术

Development and validation of a novel bioanalytical method for the simultaneous determination of glecaprevir and pibrentasvir in human plasma using reversed-phase high-performance liquid chromatography

Published:2022 Issue:4 Volume:21 Page:424
ISSN:1687-4315
Container-title:Egyptian Pharmaceutical Journal
language:en
Short-container-title:Egypt Pharmaceut J

Author:

Narender Malothu,Pavani Bonagiri,Prasanth Dintakurthi Sree Naga BalaKrishna,Guntupalli Chakravarthi

Publisher

Medknow

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Pharmaceutical Science,Toxicology,Biochemistry, Genetics and Molecular Biology (miscellaneous),Applied Microbiology and Biotechnology

Reference20 articles.

1. World Health Organization. Global hepatit is report 2017: web Annex B: WHO estimates of the prevalence and incidence of hepatitis C virus infection by WHO region, 2015. Geneva, Switzerland: World Health Organization; 2018.

2. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C;Pawlotsky;J Infect Dis,1995

3. Hepatocellular carcinoma: an epidemiologic view;El-Serag;J Clin Gastroenterol,2002

4. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing;Omata;Hepatol Int,2016

5. Liver transplantation for alcoholic liver disease;Varma;World J Gastroenterol,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of the direct acting antivirals glecaprevir and pibrentasvir in plasma;Journal of Pharmaceutical and Biomedical Analysis;2023-10